BioLife Solutions, Inc.
BLFS
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, inclā¦ read more
Healthcare
Medical Instruments & Supplies
36 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$24.95
Price-1.81%
-$0.46
1Y
Price
Market Cap
$1.201b
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+9.1%
EBITDA Margin+2.2%
Net Profit Margin+10.0%
Free Cash Flow Margin+9.1%
EBITDA Margin+2.2%
Net Profit Margin+10.0%
Free Cash Flow MarginRevenue
$74.005m
-10.0%
1y CAGR+11.8%
3y CAGR-0.2%
5y CAGREarnings
-$3.206m
+84.1%
1y CAGR+68.7%
3y CAGR-315.8%
5y CAGREPS
-$0.07
+84.1%
1y CAGR+69.7%
3y CAGR-280.4%
5y CAGRBook Value
$353.739m
$392.081m
Assets$38.342m
Liabilities$20.677m
DebtDebt to Assets
5.3%
-4.2x
Debt to EBITDAFree Cash Flow
$10.562m
+103.0%
1y CAGR+76.8%
3y CAGR+46.9%
5y CAGRNo items found.
Press Releases
Statements and updates from the company